JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-cou...

FDA Drug Recall #D-0468-2023 — Class II — March 9, 2023

Recall Summary

Recall Number D-0468-2023
Classification Class II — Moderate risk
Date Initiated March 9, 2023
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Boehringer Ingelheim Pharmaceuticals, Inc.
Location Ridgefield, CT
Product Type Drugs
Quantity 69,375 bottles

Product Description

JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597-0153-90) bottles, Rx only, Marketed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA and Eli Lilly and Company Indianapolis, IN 46285 USA

Reason for Recall

Labeling: Label Mix-up

Distribution Pattern

Product was distributed nationwide within the United States and PR

Lot / Code Information

Lot #: a) and b) E61835, exp. date JUN 2025

Other Recalls from Boehringer Ingelheim Pharmaceuticals,...

Recall # Classification Product Date
D-0600-2021 Class II Micardis Tablets, (telmisartan Tablets) 80 mg, ... May 4, 2021
D-0051-2021 Class II Catapres (clonidine hydrochloride, USP) 0.1 mg... Oct 5, 2020
D-0052-2021 Class II Catapres (clonidine hydrochloride, USP) 0.2 mg... Oct 5, 2020
D-0053-2021 Class II Catapres (clonidine hydrochloride, USP) 0.3 mg... Oct 5, 2020
D-0991-2019 Class III Mirapex (pramipexole dihydrochloride) Tablets, ... Mar 7, 2019

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.